Search Ontology:
ChEBI

nimodipine

Term ID
CHEBI:7575
Synonyms
  • 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester
  • 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
  • BAY e 9736
  • isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
  • isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
  • Nimodipine
  • nimodipino
  • nimodipinum
  • Nimotop
  • Periplum
Definition
A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
References
  • cas:66085-59-4
  • drugbank:DB00393
  • drugcentral:1937
  • kegg.compound:C07267
  • kegg.drug:D00438
  • lincs.smallmolecule:LSM-1659
  • patent:DE2117571
  • patent:US3799934
  • pubmed:12137606
  • pubmed:16180362
  • pubmed:17110283
  • pubmed:21869451
  • pubmed:22262041
  • pubmed:22300914
  • pubmed:8519001
  • reaxys:459792
  • wikipedia.en:Nimodipine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from nimodipine
Phenotype where environments contain nimodipine
Phenotype modified by environments containing nimodipine
Phenotype affecting nimodipine
Human Disease Model